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Early region 4 (E4) of bovine adenovirus type 3 (BAV-3) was analyzed by Northern blotting, RT–PCR analysis, cDNA
sequencing, and S1 nuclease protection assays. The transcriptional map of the E4 region of BAV-3 has marked dissimilarities
from those of mouse adenovirus-1, ovine adenovirus-287, and human adenovirus-2, for which the transcriptional maps have
been constructed. The E4 region of BAV-3, located between 98.6 and 89.8 MU transcribes seven distinct classes of bovine
adenovirus type 3 mRNA. The seven mRNA species formed by the removal of one to three introns share both the 39 end and
a short 59 leader (25 nucleotides). The E4 mRNAs can encode at least five unique polypeptides, namely, 143R1, 69R, 143R2,
268R, and 219R. Isolation of a replication-competent recombinant “BAV404” containing 1.9-kb insertion [glycoprotein (gD) of
bovine herpesvirus 1, under the control of a SV40 early promoter and poly(A)] in the region between E4 and the right ITR
suggested that this region is nonessential for BAV-3 replication. Expression of gD by BAV404 recombinant virus was
confirmed by immunoprecipitation with gD-specific monoclonal antibodies. Analysis of the kinetics of protein expression
indicated that gD is expressed at both early and late times postinfection. These results suggest that: (a) E4 produces seven
59–39 coterminal mRNAs and (b) the right terminal region of BAV-3 can be used for the expression of vaccine antigens. © 1999
Academic Press
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dAdenovirus-based mammalian cell expression vectors
ave gained considerable importance in the last few
ears as possible vehicles for recombinant vaccine de-
ivery and for gene therapy (Anderson, 1998; Grunhaus
nd Horwitz, 1992; Verma and Somia, 1997). Due to
nherent problems associated with the use of human
denoviruses (HAV), the focus is shifting to developing
nimal adenoviruses for gene therapy (Paillard, 1997).
e have chosen bovine adenovirus type 3 (BAV-3) with
he aim of developing it as a human gene therapy vector
nd also as a live viral vector for animal vaccination.
The E4 region of HAVs is approximately 2.8 kb in size
nd lies at the right end of the genome (Virtanen et al.,
984). The E4 region encodes functions required for DNA
eplication, late gene expression, and host cell protein
ynthesis shutoff (Halbert et al., 1985; Weinberg and
etner, 1986). The E4 transcription unit is very complex
nd is transcribed form right to left. DNA sequence
nalysis and mRNA mapping studies suggest that HAV-2
4 encodes a minimum of seven proteins (Freyer et al.,
984; Tigges and Raskas, 1984; Virtanen et al., 1984). All
xcept open reading frame (Orf) 6 are dispensable for
irus growth in vitro (Bridge and Ketner, 1989; Huang and
Published with the permission of the Director of VIDO as Journal
eries 265.
1 To whom correspondence and reprint requests should be ad-
(ressed. Fax: (306) 966-7478. E-mail: Tikoo@sask.usask.ca.
143earing, 1989). Over the past few years, it has become
rudent to delete this region from the vectors because of
afety concerns, namely, the observations that (a) Orf1 of
AV-9 has transforming capacity (Javier, 1994), (b) Orf6 of
AV-2/5 can block p53-mediated transcriptional activa-
ion (Dobner et al., 1996), and (c) the Orf6 in cooperation
ith E1A can have oncogenic potential (Moore et al.,
996). The viruses that retain the ability to express Orf6
re capable of supplying E4 functions for growth in vitro
Bridge and Ketner, 1989) and complement a complete
4 deletion in transient transfection assays (Ketner et al.,
989). In addition, cell lines expressing E4Orf6 have also
een used to develop HAV vectors containing complete
eletions of the E4 region (Weinberg and Ketner, 1983;
rougliak and Graham, 1995; Brough et al., 1996).
Bovine adenoviruses belong to the Mastadenovirus
enus of the family Adenoviridae and are involved in
ubclinical respiratory and enteric infections in cattle
Darbyshire et al., 1965). Ten known serotypes of bovine
denoviruses are subdivided into two groups based on a
umber of characteristics, which include the presence or
he absence of a complement fixing (CF) antigen com-
on to Mastadenoviruses (Bartha, 1969) and the ability
o grow in different cell lines of bovine origin (Benko et
l., 1989). BAV-3, a member of subgroup I, is the best
haracterized of all the BAV serotypes. Recently, we
etermined the entire nucleotide sequence of BAV-3Baxi et al., 1998; Lee et al., 1998; Reddy et al., 1998) and
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144 BAXI ET AL.stablished the transcription maps of the E1 (Reddy et
l., 1999), E3 (Idamakanti et al., 1999), and late regions
Reddy et al., 1998) of BAV-3. In addition, we constructed
eplication-competent recombinant BAV-3 expressing
ovine herpesvirus-1 glycoprotein D (gD) (Zakhartchouk
t al., 1998) and demonstrated the induction of protective
mmune responses against BHV-1 in calves immunized
ntranasally with these recombinants (Zakhartchouk et
l., 1999).
Although the size and location of the BAV-3 E4 region
s similar to that of HAVs, only one (219R) of the five
otential proteins shows partial homology to a 34-kDa
rotein of HAV-2 (Lee et al., 1998). Since the BAV-3 E4
egion showed little homology to the E4 region of other
denoviruses, we chose to analyze this region in more
etail. Here we report the establishment of a transcrip-
ion map of the E4 region of BAV-3 and the identification
f a nonessential site for the expression of a foreign
ene.
RESULTS
orthern blot analysis of the E4 region
Northern blot analysis was performed to determine
he transcripts originating from the E4 region of BAV-3.
otal RNA, collected at different times postinfection,
as fractionated by electrophoresis in a denaturing
garose gel, blotted on to a nitrocellulose filter, and
robed with a 784-bp DNA probe (nt 33316–34059; nt
umbers are based on BAV-3 genome sequence; Gen-
ank Accession No. AF030154). As seen in Fig. 1, the
NA probe hybridized to five transcripts of 3.1, 2.7, 2.4,
.5, and 1.3 kb. Two transcripts (2.7 and 2.4 kb) ap-
eared at 6 h postinfection, one transcript (1.3 kb)
FIG. 1. Northern blot analysis of E4 transcription from 89.8 to 100 map
ells in the presence of AraC (100 ml/ml) from 6 to 48 hr post infection
ethods” using two different probes. (A) Random labeled SwaI–SspI (n
nd labelled 26bp oligo (TGGTTTTGGCTCACAACAAATTACAA; nt. 3095
stimated sizes of the RNAs in kb.ppeared at 12 h postinfection, and two transcripts (3.1 dnd 1.5 kb) appeared at 18 h postinfection. Since the
ells were treated before and during infection with
iral DNA synthesis inhibitor (AraC), all these tran-
cripts appear to be of the early class. As DNA se-
uence analysis identified only one consensus poly-
denylation signal downstream of Orf5 (Lee et al.,
998), we wished to determine if these transcripts are
oterminal. Northern blots were probed with a syn-
hetic oligonucleotide (TGGTTTTGGCTCACAACAAAT-
ACAA; nt 30952–30977) derived from the 39 end of E4
egion (sequence complementary to the E4 mRNA
trand). The oligonucleotide hybridized to all five tran-
cripts of 3.1, 2.7, 2.4, 1.5, and 1.3 kb (Fig. 1B). These
esults suggest that all five different classes of E4
RNAs are transcribed in the same direction and have
common polyadenylation site at nucleotide 30952c
“c” denotes the bottom strand sequence). Maximum
eactivity of these transcripts with randomly labeled
ouble-stranded DNA probe compared to 59 end-la-
eled oligo probe may be due to the differences in the
pecific activities of the probes.
I nuclease analysis
To map the 59 and 39 end of the mRNAs transcribed
rom the E4 region of BAV-3, a SI nuclease protection
ssay was performed. For 39 end mapping, a BamHI–
raIII (390 bp; nt 30856–31240) fragment was generated
y PCR and labeled at the 39 end with a 32P. After
igestion of the hybridized probe with SI nuclease, a
ajor fragment of 307 bp was protected (Fig. 2A). This
ndicates that the transcripts generated from the E4 re-
ion terminate at nt 30933c, 14 bp downstream of the 39
nd of the E4 polyadenylation signal at nt 30952c. The “c”
otal RNA was isolated from mock-infected (M) or BAV-3 infected MDBK
nalyzed by Northern blot analysis as described under “Materials and
6-34059) fragment from 59 end of the E4 region. (B) Strand specific 59
7) from the 39 end of the E4 region. Numbers on the right denote theunits. T
and a
t. 3331
2-3097esignates the bottom strand sequence. For 59 end map-
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145BAV-3 E4 mRNA AND RECOMBINANT VIRUSing, a BamHI–AflIII (471 bp; nt 33762–34227) fragment
as generated by PCR and labeled at the 59 end with g
32P. On hybridization to BAV-3 RNA and subsequent di-
estion with SI nuclease, a major fragment of 186 bp was
rotected (Fig. 2B). This suggested that the transcription
n the E4 region initiates at nt 33948c, 22 bp downstream
f the TAAAATA box at nt 33966c.
nalysis of cDNA library form BAV-3 E4
Two different approaches were used to determine the
tructure of BAV-3 E4 transcripts. First, the cDNA was
onstructed using mRNA extracted from BAV-3-infected
ells at 8 and 18 h postinfection. cDNA clones containing
4 sequences were identified by colony hybridization,
sing an E4-specific 784-bp DNA probe (nt
3316–34059). A total of 40 different cDNA clones were
ompletely sequenced. Second, RT–PCR was performed
n RNA extracted from BAV-3-infected cells at 18 and
4 h postinfection. Based upon SI nuclease analysis,
ommon 59 and 39 primers in the E4 region were used to
enerate cDNA of three different sizes (Fig. 3), which
ere completely sequenced. Several clones were found
o start at the A position (nt 33948c) in the 59-TCACTT-39
equence and all the cDNA clones had their poly(A)
FIG. 2. S1 nuclease analysis of 59 and 39 ends of BAV-3 E4 mRNAs.
otal RNA was isolated from mock or BAV-3 infected (Test) MDBK cells
t 18 hr post infection (A) The 390bp (nt. 30856-31240) fragment was
sed as a probe to map the 39 end. (B) The 471bp (nt. 33762-34227)
ragment was used as a probe to map the 59 end. RNA in the test lane
epresents the S1 nuclease protected fragments ( ). Lanes T, C, G, A,
epresent sequence ladder as a marker.ddition site at T (nt 30933c) in the sequence 59-ACTTAA- o9. The poly(A) addition site for the fiber transcript is
ocated 7 bp upstream of the E4 poly(A) addition site but
s on the opposite strand (Reddy et al., 1998).
A comparison between the obtained cDNA sequences
nd the known nucleotide sequence of the BAV-3 E4
egion (Lee et al., 1998) made it possible to deduce the
olecular structures of seven different transcripts of E4,
ncluding splice acceptor and donor sites. The proposed
tructures of seven E4 transcripts designated A to G are
epicted in Fig. 4 and summarized in Table 1. All the
ranscripts originating from the E4 region are 59 and 39
oterminal. It is therefore likely that they are processed
rom a common precursor RNA (transcript A) extending
rom the cap site located at nucleotide 33948c to the
oly(A) stop site at nucleotide 30933c. All E4 transcripts
A to G) have a common 59 leader, 25 bp in length (nt
3948–33913c). Transcripts B to E have a second leader
f 258 bp (nt 33576 to 33315c), which contains the non-
oding repetitive sequences. Transcripts C and D have a
hird leader of 187 bp in length (nt 33065c–32878c).
The E4 region in BAV-3 is subjected to splicing (Fig. 4).
here are between one and three introns removed dur-
ng the maturation of different E4 mRNA species. Tran-
cript A did not show any splicing and probably repre-
ents the primary transcript of the region. Transcripts B,
, and G have one intron removed, transcripts C and E
ave two introns removed, and transcript D has three
ntrons removed (Table 1). In transcripts F and G, the
ntron brings the 59 leader in close proximity to the first
UG of various Orfs. The size of the intron varies in each
ranscript and spans from a common donor (D1) to dif-
erent acceptor sites (A1, A4, or A5). The introns in spe-
ies C and E have common donor sites (D1 and D2) but
ifferent acceptor sites (A3 or A4).
Lee et al. (1998) identified and determined the nucle-
tide sequence of the E4 region of BAV-3. Analysis of the
equence identified five Orfs, which have the potential to
ode for 143R1, 69R, 268R, 143R2, and 219R proteins.
FIG. 3. RT-PCR analysis of the E4 region of BAV-3. Total RNA isolated
rom BAV-3 infected MDBK cells at 18 and 24 hr post infection was used
o generate oligo(dT)-primed cDNA. The E4 specific cDNA were further
mplified with E4 specific primers (described in materials and meth-
ds) and the products were analyzed on 1.2% agarose gel.
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146 BAXI ET AL.ranscript A did not show any splicing and may code for
he 143R1 protein. Transcripts B and C may code for 69R
nd 268R proteins, respectively. Although transcripts D,
, and F show different splicing patterns, they all may
ode for the 143R2 protein. Transcript G may code for the
19R protein.
onstruction of recombinant BAV-3 expressing BHV-1
lycoprotein D
In order to determine a nonessential site for the insertion
f a foreign gene, bovine herpesvirus-1 glycoprotein D
FIG. 4. Location of E4 transcripts on the BAV-3 genome. The upperlin
nd map units indicated. The E4 region of BAV-3 extends from m.u. 98.6
IR1 and IR2), TATA box and poly A site are illustrated. The thick lines
RNA species from the cDNA library that hybridized to SwaI–SspI (
tarting the open reading frames in mRNA B and G are marked ( u ).
T
Major Landmarks in E
mRNA Gene/protein
Transcription
start site ATG
Sp
don
A Orf1/143R1 33948 33888
B Orf2/69R 33948 33305 3391
C Orf3/268R 33948 32829 3391
3331
D Orf4/143R2 33948 32001 3391
3331
3287
E Orf4/143R2 33948 32001 3391
3331
F Orf4/143R2 33948 32001 3391
G Orf5/219R 33948 31631 3391a The positions given in the table are based on the complementary strandene was inserted in a site between the E4 region and the
ight ITR. Using the homologous recombination machinery
f Escherichia coli, we constructed a plasmid (pFBAV404)
hat contained a gD transcriptional cassette (gD gene
lanked by SV40 early promoter and SV40 poly(A)) inserted
t the SspI site (nt 34059) in the same transcriptional ori-
ntation as that of E4 (Fig. 5). Since Bst1107I restriction
nzyme site is present in pFBAV302 (1.245-kb E3 deletion;
akhartchouk et al., 1998), and one is present in the gD
ene, we digested the plasmids with Bst1107I restriction
nzyme. As expected, compared to pFBAV302 (Fig. 6, lane
sents the right end of the BAV-3 genome with nucleotide (nt) numbers
from right to left. Some of the unique feature such as internal repeats
the exons and thin lines depict the introns. The structure of 7 unique
are illustrated. Shaded arrows are open reading frames 1 to 5. AUGs
tarting the open reading frames are indicated (u ).
ovine Adenovirus 3a
Splice
acceptor site Stop site
Poly(A)
signal
Transcription
stop
33457 30952 30933
33627 (A1) 33096 30952 30933
33576 (A2) 32023 30952 30933
33065 (A3)
33576 (A2) 31570 30952 30933
33065 (A3)
32005 (A4)
33576 (A2) 31570 30952 30933
32005 (A4)
32005 (A4) 31570 30952 30933
31653 (A5) 30972 30952 30933e repre
to 89.8
depicts
) probeABLE 1
4 of B
lice
or site
3 (D1)
3 (D1)
5 (D2)
3 (D1)
5 (D2)
8 (D3)
3 (D1)
5 (D2)
3 (D1)
3 (D1)of the BAV-3 genome.
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147BAV-3 E4 mRNA AND RECOMBINANT VIRUS), Bst1107I restriction enzyme digestion of pFBAV404
which contained the gD gene) produced two bands (Fig. 6,
ane b). Transfections of fetal bovine retina cells (FBRC) with
acI-linearized pFBAV404 DNA produced cytopathic effects
n 14 days. The infected cell monolayers were freeze-
hawed and the recombinant virus was plaque purified and
ropagated on MDBK cells. The recombinant BAV was
amed BAV404. The presence of the gD gene was con-
irmed by analysis of restriction enzyme-digested viral DNA
sing agarose gel electrophoresis. Since one Bst1107I
estriction enzyme site is present in the BAV3.E3d genome
1.245-kb E3 deletion; Zakhartchouk et al., 1998) and one is
FIG. 5. Construction of plasmid pFBAV404. Schematic diagram of pFB
rom pFBAV302 (nt 30833 to 34446) was self ligated and used for the in
ntron and SV40polyA) at the SspI site (nt 34059) in the right terminal re
ecombination between AgeI-AhdI fragment of E4 polyIISn.gD and Sw
FBAV404. ITR’s (black boxes), BAV3 genomic DNA (open boxes), pA (
lasmid sequence (thin line) and plasmid excision (PacI) and linearizaithin the gD gene (Tikoo et al., 1990), the viral DNA was [igested with Bst1107I. As seen in Fig. 6, BAV404 has a
and of 872 bp (Fig. 6, lane d), which is missing in BAV3.E3d
Fig. 6, lane c). Southern blot analysis of the Bst1107I-
estricted BAV3.E3d and BAV404 DNA confirmed the pres-
nce of the gD gene in the recombinant virus (data not
hown).
xpression of gD by BAV404
To analyze the products expressed by recombinant
AV404, MDBK cells were infected with recombinant
AV404, BAV3.E3d, or BHV-1 and metabolically labeled with
depicting some restriction enzymes sites. The EcoRI terminal fragment
of the gD gene (flanked by SV40 immediate early promoter-chimeric
BAV-3 genome to generate the plasmid E4 polyII Sn.gD. Homologous
ted full length plasmid pFBAV302 was used to generate the plasmid
olyA), Int (chimeric intron), SV40pro(SV40 early promoter), FIB (Fiber),
th SwaI restriction enzyme are also indicated.AV302
sertion
gion of
aI diges35S]methionine–cysteine at various times postinfection. Ex-
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148 BAXI ET AL.ression of gD was monitored by immunoprecipitation of
nfected cell lysates with a pool of gD-specific monoclonal
ntibodies (Hughes et al., 1988) and analysis by SDS–
olyacrylamide gel electrophoresis (PAGE) under reducing
onditions. A major band of ;71 kDa was observed in cells
nfected with BAV404 (Fig. 7), which comigrated with the gD
xpressed in BHV-1-infected cells (Fig. 7). No similar band
as detected in mock- or BAV3.E3d-infected cells (Fig. 7).
he gD expression was observed from 12 to 48 h postin-
ection (Fig. 7). To determine whether gD expression oc-
FIG. 6. Restriction enzyme analysis of recombinant genomes. The
NAs were extracted from recombinant viruses BAV3.E3d (lane c),
AV404 (lane d), and plasmids pFBAV302 (lane a) and pFBAV404 (lane
), and digested with Bst1107I. 1 kb DNA ladder (lane M) was used for
izing the DNA fragments. The marker band is shown by arrow.
FIG. 7. Immunoprecipitation analysis of BAV404 infected MDBK cells
ith BAV3, BHV-1 or BAV404 and labeled with 35S-methionine. Protein
nfection were immunoprecipitated with a pool of gD specific MAbs an
f AraC on gD expression, MDBK cells were infected in the presence
ize markers (MW) are given in kDa.urred in the absence of viral DNA replication, MDBK cells
ere infected in the presence of an inhibitor of viral DNA
ynthesis, 1-b-D-arabinofuranosylcytosine (AraC). As seen
n Fig. 7, gD expression was markedly reduced in the
resence of AraC (Fig. 7), suggesting that the expression of
D in MDBK cells occurred both before and after viral DNA
ynthesis.
DISCUSSION
The E4 region of HAVs encode proteins, which are
nvolved in modulation of gene expression and replica-
ion of virus, including transformation and apoptosis (re-
iewed by Leppard, 1997). Recent studies have also
uggested that the presence or absence of the E4 region
n HAV vectors may determine the duration of transgene
xpression in animals (Armentano et al., 1997; Kaplan et
l., 1997). Since RNA transcripts and the proteins en-
oded by the E4 region of adenoviruses differ consider-
bly, these functions may not be retained by the E4
egions of different adenoviruses. Hence, detailed stud-
es are required to determine precisely the structure and
unction of proteins encoded by the E4 regions of adeno-
iruses. We are carrying out molecular characterization
f BAV-3 (Baxi et al., 1998; Idamakanti et al., 1999; Lee et
l., 1998; Reddy et al., 1998, 1999) with the aim of devel-
ping it as a vector for gene therapy and a live viral
accine for animals (Zakhartchouk et al., 1998, 1999). In
his report, we describe the construction of a transcrip-
ional map of the E4 region and identification of a non-
ssential region for the insertion of a foreign gene in
AV-3.
Northern blot analysis revealed at least five classes of
RNA, which are exclusively transcribed from right to left
rom the E4 region of BAV-3. Like HAV-2 (Dix and Lepp-
rd, 1993; Virtanen et al., 1984), ovine adenovirus-287
ent monolayers of MDBK cells were either mock infected, or infected
lysates of radiolabeled cells harvested at 12, 24, 36 and 48 hr post
zed on 10% SDS-PAGE under reducing conditions. To study the effect
ml/ml AraC. The arrow indicated 71 kDa gD specific band. Molecular. Conflu
s from
d analy
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149BAV-3 E4 mRNA AND RECOMBINANT VIRUSOAV287; Khatri and Both, 1998), and mouse adenovi-
us-1 (MAV-1; Kring et al., 1992), the E4 region of BAV-3 is
ranscriptionally active at early and late times postinfec-
ion. The BAV-3 E4 transcripts identified by cDNA analy-
is correlated well with the classes seen with Northern
lotting. However, two smaller transcripts (F and G)
ould not be detected with Northern blotting. By using a
ore sensitive RT–PCR, we were able to amplify these
wo smaller transcripts. This may be due to the low
bundance of these transcripts in BAV-3-infected cells.
Like other adenoviruses, the E4 region of the BAV-3 is
ocated at the extreme right end of the BAV-3 genome
rom map units 98.6 to 89.8 (Lee et al., 1998). The entire
AV-3 E4 transcriptional unit was found to be 3005 bp in
ength, which is larger than the E4 of MAV-1 (Kring et al.,
992), PAV-3 (Reddy et al., 1997), OAV287 (Khatri and
oth, 1998) and HAV-2 (Virtanen et al., 1984). All BAV-3 E4
RNAs share a short untranslated leader and are 39
oterminal, a feature observed in the E4 region of HAV-2
Virtanen et al., 1989). In contrast, the MAV-1 (Kring et al.,
992) and OAV287 (Khatri and Both, 1998) E4 mRNAs are
9 coterminal but contain a heterogeneous 59 end.
The E4 region of HAV-2 is predicted to encode seven
ifferent polypeptides as a result of extensive splicing in
he E4 region that produces an array of at least 18
istinct mRNAs (Virtanen et al., 1984). However, like
AV-1 (Kring et al., 1992) and OAV287 (Khatri and Both,
998), the E4 region of BAV-3 appears to be less com-
lex, as it is predicted to encode five polypeptides from
even distinct mRNAs. In the case of HAV-2, Orfs 3/4 and
/7 are produced as a result of alternate splicing of
rimary transcripts (Virtanen et al., 1984). Like MAV-1
Kring et al., 1992) and OAV287 (Khatri and Both, 1998), no
uch spliced transcripts were identified in the E4 region
f BAV-3. Although proteins encoded by Orf3 and Orf5 of
AV-3 E4 show partial homology to the 34-kDa protein of
he HAV-2 E4 region and its homologs, the conserved
otif HCHXXPGSLQ present in the 34-kDa protein of
AV-2 (Virtanen et al., 1984), the 30.8-kDa protein of
AV287 (Vrati et al., 1996), and the a/b Orf of MAV-1 (Kring
t al., 1992) is present only in BAV-3 E4 Orf5.
Unlike HAV-2 (Virtanen et al., 1984), two potential TATA
oxes (nt 33966c and 34202c) are located upstream of
he E4 region of BAV-3 (Lee et al., 1998). However, cDNA
equencing and 59 end mapping experiments suggested
hat the TATA box located at 33966c is primarily utilized
s a promoter for E4 transcription of BAV-3. Similarly, one
f the two potential TATA boxes located upstream of E4
f PAV-3 is utilized as a promoter for the transcription of
he E4 region (Reddy et al., 1998). In contrast, two poten-
ial TATA boxes located upstream of the E4 region of
AV287 have been shown to act as promoters for the
ranscription of the E4 region (Khatri and Both, 1998).
ike HAV-2 (Virtanen et al., 1984), BAV-3 E4 transcripts
riginating from the E4 promoter contain many introns,
hich are removed to generate different mRNAs (A to G). mhus during the transcription process one to three in-
rons are removed to generate the mature form of BAV-3
4 mRNAs. This suggests that multiple E4 proteins arise
rom differential splicing of the BAV-3 primary transcript.
similar mechanism has been proposed for HAV-2 (Vir-
anen et al., 1984). However, in OAV287 (Khatri and Both,
998) and MAV-1 (Kring et al., 1992), the multiple E4
roteins may arise from different transcripts. Interest-
ngly, in some of the transcripts the first AUG is far away
rom the leader sequence. In transcripts B, C, D, and E
he first AUG is 322, 492, 443, and 300 bp away from the
9 leader, respectively. How efficiently these mRNAs are
ranslated in vivo and their effect on viral replication
emain to be determined.
The region between the E4 promoter and the right ITR
f HAV-5 is transcriptionally inactive (Saito et al., 1985)
nd is not essential for virus replication, as viable recom-
inant HAVs containing insertions in this region can be
solated (Chanda et al., 1990; Manson et al., 1990;
akimura et al., 1996). Although a second potential pro-
oter is located (nt 34202) in the region between the E4
romoter (nt 33966c) and the right ITR (34263c to 34446c)
f BAV-3 (Lee et al., 1998), no transcript originating from
his promoter was detected in the present study. In ad-
ition, the isolation of a replication-competent recombi-
ant BAV-3 containing 1.9 kb of foreign DNA inserted at nt
4059 in this region suggests that it is not essential for
AV-3 replication.
Foreign genes with different flanking regulatory se-
uences, inserted in the region between the E4 promoter
nd the right ITR of HAVs, are expressed efficiently
Chanda et al., 1990; Manson et al., 1990; Makimura et
l., 1996). We constructed recombinant BAV404 in which
he gD expression is driven by a SV40 early promoter.
lycoprotein gD expression, observed from 12 to 48 h
ostinfection, was partially reduced in the presence of
raC, suggesting that the SV40 early promoter was ac-
ive before and after viral DNA synthesis. The gD ex-
ressed by recombinant BAV404 was of the expected
olecular weight and comigrated with the authentic gD
xpressed in BHV-1-infected cells. This suggested that
he recombinant gD contains posttranslational modifica-
ions indistinguishable from those of authentic gD syn-
hesized after viral infections (Hughes et al., 1988).
The knowledge gained about the organization of the
4 region should help in determining the structure and
unction of the encoded protein. Work is in progress to
enerate E4 deletion mutants and E4 deletion-based
ecombinants.
MATERIAL AND METHODS
ells and viruses
Fetal bovine retina cells (FBRC) and Madin–Darby bo-
ine kidney cells (MDBK) cells were grown in Eagle’s
inimum essential medium (MEM) in the presence of
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150 BAXI ET AL.0% fetal bovine serum (FBS). The BAV-3 strain WBR-1
as propagated in MDBK cells according to published
rotocols (Reddy et al., 1998). The P8-2 strain of BHV-1
as propagated as described (Rouse and Babiuk, 1974).
he virus was purified as described earlier (Tollefson et
l., 1998).
NA isolation
Total cellular RNA was isolated from mock- or BAV-3-
nfected MDBK cells as described by Chomcyznski and
acchi (1987). Briefly, mock- or BAV-3-infected MDBK
ells grown in the presence of AraC (100 ml/ml), collected
rom 6 upto 48 h postinfection, were lysed with cell lysis
uffer [containing equal amounts of water-saturated phe-
ol and solution D (4 M guanidine, 50 mM EDTA, 25 mM
itric acid, 0.5% Sarcosul), 0.1 M sodium acetate, and
.7% b-merceptoethanol]. After treating the cell lysate
ith choloroform–isoamyl alcohol solution, the RNA was
recipitated with isopropanol and finally dissolved in
EPC–water.
orthern analysis
Equal amounts of RNA (10 mg/ml) were run through 1%
garose gels containing formaldehyde (Sambrook et al.,
989). Following electrophoresis, RNA was transferred to
ylon membranes and baked for 2 h at 80°C under
acuum. The DNA probes used for hybridization were
abeled with [a-32P]dCTP by the random labeling method
Gibco BRL). Oligonucleotides were labeled with
g-32P]ATP and T4 polynucleotide kinase (Sambrook et
l., 1989). Hybridization was carried out overnight at
2°C and the membranes were washed in the presence
f 0.1% SDS to remove unbound probe (Khattar et al.,
995). Finally, the membranes were air-dried and ex-
osed to X-Omat AR film at 270°C.
onstruction of cDNA library
Total poly(A) RNA was extracted from BAV-3-infected
DBK cells at 8 and 18 h to construct the cDNA libraries.
he cDNAs were synthesized using the ZAP Express
DNA synthesis kit (Stratagene). Briefly, first-strand syn-
hesis was carried out using MMLV reverse transcrip-
ase and double-stranded cDNAs were generated using
NA polymerase I. The cDNAs were inserted into a
ni-Zap vector and transformed in E. coli XL-1 Blue MRF’
ells. Positive clones representing the BAV-3 E4 region
ere identified by Southern blot analysis. 32P-labeled
waI–SspI (Fig. 4; nt 33316–34059) probe from the 59 end
f the E4 region was used to screen the cDNA library.
he positive clones were twice plaque purified. Finally,
he Bluescript(SK1) containing cDNA were excised from
he Uni-Zap vector and transformed in E. coli cells. The
elected clones were grouped by restriction enzyme
nalysis and sequenced completely (Sanger et al., 1977). tnalysis of RNA transcripts using RT–PCR
Total RNA was prepared from BAV-3-infected MDBK
ells at 18 and 24 h postinfection. First-strand cDNA was
ynthesized using MuLV reverse transcriptase and oli-
o(dT) primer (Perkin–Elmer). A sequence-specific set of
rimers (59 end primer, TGGTTTTGGCTCACAACAAATTA-
AA, and 39 end primer, TTCACTTGCGGCAGCTC-
AGCTG) was used to further amplify the cDNA products
y amplifying for 35 cycles (95°C for 1 min, 55°C for 1
in, and 72°C for 2 min) in the thermal cycler (Fig. 3). The
mplified products were blunt ended with T4 DNA poly-
erase, ligated to SmaI-digested pGEM3Z(1) plasmid,
nd finally sequenced as described (Sanger et al., 1977).
1 nuclease analysis
The protocol of Sambrook et al. (1989) was followed for
1 nuclease analysis to locate the 59 and 39 termini of E4
RNA. The probes used to detect the ends were di-
ested with appropriate enzymes and end labeled with
g-32P]ATP using polynucleotide kinase for the 59 end and
ith [a-32P]dCTP using a Klenow fragment for the 39 end
Sambrook et al., 1989). The labeled fragments were
igested with a second enzyme to remove the label at
he other end and then gel purified. Hybridization with
oly(A) RNA was carried out at 42°C overnight. The
amples were treated with 200 U of S1 nuclease for 1 h
o digest the unhybridized RNA and DNA. Finally, S1
uclease reactions were analyzed on 6% acrylamide/8 M
rea sequencing gels.
onstruction of recombinant plasmids
A schematic representation of generating the full-
ength BAV-3 genomic DNA clone containing the BHV-
gD gene inserted between the E4 region and the right
TR (pFBAV404) is described in detail in Fig. 5. Plasmid
FBAV302 containing a deletion in the E3 region (Zak-
artchouk et al., 1998) was digested with EcoRI and a
625-bp fragment (containing the right terminal EcoRI
ragment of the BAV-3 genome) was self-ligated to gen-
rate the plasmid E4polyIISn containing the complete E4
nd right ITR. The 3632-bp EcoRI–NotI fragment isolated
rom E4polyIISn was ligated to EcoRI–NotI-digested
lasmid pCR2.1 (Invitrogen) to create the plasmid
4pCR2.1. A 1.9-kb fragment containing BHV-1 full-length
D under the control of an immediate early SV40 pro-
oter, having a chimeric intron at the 59 end and SV40
oly(A) at the 39 end, was inserted at a unique SspI
estriction enzyme site of plasmid E4pCR2.1 to generate
4pCR2.1.gD plasmid. The BamHI–NotI fragment of
4polyIISn was replaced with a BamHI–NotI fragment of
4pCR2.1.gD to generate the plasmid E4polyIISn.gD. The
ull-length recombinant plasmid containing BHV-1 gD
pFBAV404) was generated by homologous recombina-
ion in E. coli BJ5183 cells between SwaI-linearized pF-
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4polyIISn.gD.
ransfections
FBRC were grown in 60-mm dishes in MEM medium
ith 10% FBS. Cells were transfected with 10 mg of
acI-digested pFBAV404 using the Ca21 phosphate
ethod (Hermiston et al., 1998). Following transfection,
ells were maintained in 2% FBS and incubated for 15–20
ays until the viral plaques appeared. Cells showing 50%
ytopathic effects were harvested and freeze-thawed
hree times, and recombinant virus was plaque-purified
n MDBK cells (Mittal et al., 1995).
mmunoprecipitations
Monolayers of MDBK cells were infected with
AV3.E3d, BHV-1, or recombinant BAV404 at a m.o.i. of 10.
t different times p.i., the cells were incubated in methi-
nine–cysteine-free Dulbucco’s modified Eagle’s me-
ium (DMEM) for 1 h before labeling with [35S]methion-
ne–cysteine (100 mCi/ml). After 2–12 h of labeling, cells
ere washed with PBS and harvested in radioimmuno-
recipitation buffer [RIPA buffer: 150 mM NaCl, 10 mM
ris (pH 7.8), 1% Triton-X, 1% sodium deoxycholate, 0.1%
DS]. Immunoprecipitations were carried out with the
ool of anti-gD monoclonal antibodies and complexes
ere captured with protein A–Sepharose beads. Precip-
tates were washed in RIPA buffer and proteins were
eparated on a 10% SDS–PAGE gel. Labeled proteins
ere visualized by autoradiography.
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